Featured publications

  • Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population

    Authors: Jiménez E; Bonnín CdM; Solé B; Sánchez-Moreno J; Reinares M; Torrent C; Torres I; Salagre E; Varo C; Ruíz V; Giménez A; Benabarre A; Gutiérrez-Rojas L; Cervilla J; Sáiz PA; García-Portilla MP; Bobes J; Amann BL; Martínez-Arán A; Vieta E.
    Reference: JOURNAL OF AFFECTIVE DISORDERS 2019.
  • Characterizing decision-making and reward processing in bipolar disorder: A cluster analysis

    Authors: Jimenez, E; Sole, B; Arias, B; Mitjans, M; Varo, C; Reinares, M; Bonnin, C M; Salagre, E; Ruiz, V; Torres, I; Tomioka, Y; Saiz, P A; Garcia-Portilla, M P; Buron, P; Bobes, J; Martinez-Aran, A; Torrent, C; Vieta, E; Benabarre, A.
    Reference: EUROPEAN NEUROPSYCHOPHARMACOLOGY 2018.
  • Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder

    Authors: Tomioka Y; Jiménez E; Salagre E; Arias B; Mitjans M; Ruiz V; Sáiz P; García-Portilla M; de la Fuente L; Gomes-da-Costa S; Bobes J; Vieta E; Benabarre A; Grande I.
    Reference: JOURNAL OF AFFECTIVE DISORDERS 2018.
  • Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group.

    Authors: Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, Versace A, Bilderbeck AC, Uhlmann A, Mwangi B, Krämer B, Overs B, Hartberg CB, Abé C, Dima D, Grotegerd D, Sprooten E, Bøen E, Jimenez E, Howells FM, Delvecchio G, Temmingh H, Starke J, Almeida JRC, Goikolea JM, Houenou J, Beard LM, Rauer L, Abramovic L, Bonnin M, Ponteduro MF, Keil M, Rive MM, Yao N, Yalin N, Najt P, Rosa PG, Redlich R, Trost S, Hagenaars S, Fears SC, Alonso-Lana S, van Erp TGM, Nickson T, Chaim-Avancini TM, Meier TB, Elvsåshagen T, Haukvik UK, Lee WH, Schene AH, Lloyd AJ, Young AH, Nugent A, Dale AM, Pfennig A, McIntosh AM, Lafer B, Baune BT, Ekman CJ, Zarate CA, Bearden CE, Henry C, Simhandl C, McDonald C, Bourne C, Stein DJ, Wolf DH, Cannon DM, Glahn DC, Veltman DJ, Pomarol-Clotet E, Vieta E, Canales-Rodriguez EJ, Nery FG, Duran FLS, Busatto GF, Roberts G, Pearlson GD, Goodwin GM, Kugel H, Whalley HC, Ruhe HG, Soares JC, Fullerton JM, Rybakowski JK, Savitz J, Chaim KT, Fatjó-Vilas M, Soeiro-de-Souza MG, Boks MP, Zanetti MV, Otaduy MCG, Schaufelberger MS, Alda M, Ingvar M, Phillips ML, Kempton MJ, Bauer M, Landén M, Lawrence NS, van Haren NEM, Horn NR, Freimer NB, Gruber O, Schofield PR, Mitchell PB, Kahn RS, Lenroot R, Machado-Vieira R, Ophoff RA, Sarró S, Frangou S, Satterthwaite TD, Hajek T, Dannlowski U, Malt UF, Arolt V, Gattaz WF, Drevets WC, Caseras X, Agartz I, Thompson PM, Andreassen OA .
    Reference: MOLECULAR PSYCHIATRY 2018.
  • Impact of childhood trauma on cognitive profile in bipolar disorder

    Authors: Jimenez, Esther; Sole, Brisa; Arias, Barbara; Mitjans, Marina; Varo, Cristina; Reinares, Maria; del Mar Bonnin, Caterina; Ruiz, Victoria; Alejandra Saiz, Pilar; Paz Garcia-Portilla, M; Buron, Patricia; Bobes, Julio; Amann, Benedikt L; Martinez-Aran, Anabel; Torrent, Carla; Vieta, Eduard; Benabarre, Antoni.
    Reference: BIPOLAR DISORDERS 2017; 19(5):363-374.
  • Clinical features, impulsivity, temperament and functioning and their role in suicidality in patients with bipolar disorder

    Authors: Jiménez E, Arias B, Mitjans M, Goikolea JM, Ruíz V, Brat M, Sáiz PA, García-Portilla MP, Burón P, Bobes J, Oquendo MA, Vieta E, Benabarre A .
    Reference: ACTA PSYCHIATRICA SCANDINAVICA 2016.
  • Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.

    Authors: L Hou; U Heilbronner; F Degenhardt; M Adli; K Akiyama; N Akula; R Ardau; B Arias; L Backlund; CE Banzato; A Benabarre; S Bengesser; AK Bhattacharjee; JM Biernacka; A Birner; C Brichant-Petitjean; ET Bui; P Cervantes; GB Chen; HC Chen; C Chillotti; S Cichon; SR Clark; F Colom; DA Cousins; C Cruceanu; PM Czerski; CR Dantas; A Dayer; B Étain; P Falkai; AJ Forstner; L Frisén; JM Fullerton; S Gard; JS Garnham; FS Goes; P Grof; O Gruber; R Hashimoto; J Hauser; S Herms; P Hoffmann; A Hofmann; S Jamain; E Jiménez; JP Kahn; L Kassem; S Kittel-Schneider; S Kliwicki; B König; I Kusumi; N Lackner; G Laje; M Landén; C Lavebratt; M Leboyer; SG Leckband; CA Jaramillo; G MacQueen; M Manchia; L Martinsson; M Mattheisen; MJ McCarthy; SL McElroy; M Mitjans; FM Mondimore; P Monteleone; CM Nievergelt; MM Nöthen; U Ösby; N Ozaki; RH Perlis; A Pfennig; D Reich-Erkelenz; GA Rouleau; PR Schofield; KO Schubert; BW Schweizer; F Seemüller; G Severino; T Shekhtman; PD Shilling; K Shimoda; C Simhandl; CM Slaney; JW Smoller; A Squassina; T Stamm; P Stopkova; SK Tighe; A Tortorella; G Turecki; J Volkert; S Witt; A Wright; LT Young; PP Zandi; JB Potash; JR DePaulo; M Bauer; EZ Reininghaus; T Novák; JM Aubry; M Maj; BT Baune; PB Mitchell; E Mitchell; MA Frye; JK Rybakowski; PH Kuo; T Kato; M Grigoroiu-Serbanescu; A Reif; M Del Zompo; F Bellivier; M Schalling; NR Wray; JR Kelsoe; M Alda; M Rietschel; FJ McMahon; TG Schulze.
    Reference: THE LANCET 2016.
  • Association between GSK3beta gene and increased impulsivity in bipolar disorder

    Authors: Jimenez, Esther; Arias, Barbara; Mitjans, Marina; Goikolea, Jose M; Roda, Esther; Ruiz, Victoria; Perez, Ana; Saiz, Pilar A; Paz Garcia-Portilla, M; Buron, Patricia; Bobes, Julio; Vieta, Eduard; Benabarre, Antoni.
    Reference: EUROPEAN NEUROPSYCHOPHARMACOLOGY 2014.
  • Genetic variability at IMPA2, INPP1 and GSK3beta increases the risk of suicidal behavior in bipolar patients

    Authors: Jimenez, E; Arias, B; Mitjans, M; Goikolea, J M; Roda, E; Saiz, P A; Garcia-Portilla, M P; Buron, P; Bobes, J; Oquendo, M A; Vieta, E; Benabarre, A.
    Reference: European Neuropsychopharmacology 2013.
  • Impulsivity and functional impairment in bipolar disorder

    Authors: Jimenez, E; Arias, B; Castellvi, P; Goikolea, J M; Rosa, A R; Fananas, L; Vieta, E; Benabarre, A.
    Reference: JOURNAL OF AFFECTIVE DISORDERS 2012.